From professional translators, enterprises, web pages and freely available translation repositories.
alemtużumab ma jidhirx li jikkawża ħsarat lil ċelluli staminali ematopoetiċi jew ċelluli proġenituri.
alemtuzumab does not appear to damage haematopoietic stem cells or progenitor cells.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
alemtużumab huwa antikorp monoklonali umanizzat tat-tip igg1 kappa magħmul permezz ta’ inġinerija ġenetika, speċifiku għal glycoprotein (cd52) fuq il-wiċċ ta’ ċellula limfoċita tat-tip 21-28 kd, li jinsab prinċipalment fuq il-wiċċ ta’ ċelluli limfoċiti b u t periferali tad-demm normali u malinni.
alemtuzumab is a genetically engineered humanised igg1 kappa monoclonal antibody specific for a 21-28 kd lymphocyte cell surface glycoprotein (cd52) expressed primarily on the surface of normal and malignant peripheral blood b and t cell lymphocytes.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
